News

We provide the latest news
from the world of economics and finance

Back
02 May
Compared to Estimates, Allstate (ALL) Q1 Earnings: A Look at Key Metrics

Allstate (ALL) reported $15.42 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 12%. EPS of $5.13 for the same period compares to -$1.30 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $15.29 billion, representing a surprise of +0.89%. The company delivered an EPS surprise of +24.82%, with the consensus EPS estimate being $4.11.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Allstate performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Combined Ratio - Property-liability: 93% compared to the 94.8% average estimate based on eight analysts.
  • Loss Ratio - Property-liability: 72.4% versus 74.2% estimated by seven analysts on average.
  • Expense Ratio - Property-liability: 20.6% versus the seven-analyst average estimate of 20.7%.
  • Expense Ratio - Homeowners: 21.8% versus the five-analyst average estimate of 20.8%.
  • Property-Liability- Net Premiums Earned: $12.90 billion compared to the $12.87 billion average estimate based on eight analysts. The reported number represents a change of +10.9% year over year.
  • Property-Liability- Net Investment Income: $702 million compared to the $582.43 million average estimate based on seven analysts. The reported number represents a change of +37.9% year over year.
  • Property-Liability- Other Revenue: $430 million compared to the $386.64 million average estimate based on seven analysts. The reported number represents a change of +21.8% year over year.
  • Allstate Health and Benefits- Accident and health insurance premiums and contract charges: $478 million compared to the $468.94 million average estimate based on six analysts.
  • Corporate and Other- Net Investment Income: $18 million versus $26.61 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -41.9% change.
  • Revenues- Net investment income: $764 million compared to the $662.29 million average estimate based on six analysts. The reported number represents a change of +32.9% year over year.
  • Allstate Health and Benefits- Net Investment Income: $23 million versus $22.49 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +21.1% change.
  • Allstate Health and Benefits- Other Revenue: $134 million compared to the $110.49 million average estimate based on six analysts. The reported number represents a change of +32.7% year over year.

View all Key Company Metrics for Allstate here>>>

Shares of Allstate have returned -1.4% over the past month versus the Zacks S&P 500 composite's -4.1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.